FIELD: medicine. SUBSTANCE: method involves treating the anterior eye segment area with gas flow containing nitrogen oxide in 400-1000 mg/m3 concentration once from 1 to 14 days with optimum exposure time of 60 s. EFFECT: enhanced effectiveness in regulating metabolism processes in injured tissues; improved collateral blood circulation; accelerated reparative processes; inhibited cornea neovascularization processes when needed. 3 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING CORNEAL WOUND EPITHELIALIZATION | 2001 |
|
RU2192814C1 |
METHOD FOR TREATING INFLAMMATORY DISEASES AND INJURIES OF ANTERIOR EYE SURFACE | 1999 |
|
RU2178684C2 |
METHOD FOR TREATING RETINAL VEIN THROMBOSIS BY ADMINISTERING NITROGEN OXIDE DONORS AND INHIBITORS | 2002 |
|
RU2223072C2 |
METHOD FOR TREATING ANTERIOR EYE SURFACE DISEASES AND INJURIES | 1999 |
|
RU2180822C2 |
METHOD OF TREATING EYELID WOUNDS | 2010 |
|
RU2432928C1 |
METHOD FOR TREATING SECONDARY GLAUCOMA CASES | 1999 |
|
RU2164122C2 |
SURGICAL METHOD FOR TREATING CONGENITAL GLAUCOMA IN CHILDREN BY MEANS OF COMBINED ULTRASONIC TRABECULECTOMY | 2000 |
|
RU2199295C2 |
METHOD FOR MONITORING LABOR IN THE CASES OF MEDIUM OR HIGH MYOPIA SEVERITY DEGREE AND RETINA DEGENERATION | 1999 |
|
RU2157667C1 |
OPHTHALMIC DROPS FOR TREATING ALLERGIC CONJUNCTIVITIS AND KERATOCONJUNCTIVITIS | 2001 |
|
RU2193403C1 |
METHOD FOR TREATING SUBRETINAL NEOVASCULAR MEMBRANE | 2003 |
|
RU2297205C2 |
Authors
Dates
2002-11-20—Published
2001-03-05—Filed